Resumen
La estenosis valvular aórtica constituye la lesión valvular más frecuente en el mundo y en México; el pronóstico con el tratamiento médico es desfavorable a mediano y a largo plazos. Desde hace más de 50 años el tratamiento de elección ha sido el reemplazo valvular quirúrgico, y casi una tercera parte de los pacientes se consideraba en alto riesgo y quedaba fuera de manejo. En nuestro país, en 2012 se inició la implantación valvular percutánea, brindando así una nueva alternativa terapéutica a nuestros pacientes, cada vez más establecida dentro del ámbito cardiológico de México. Se presenta el caso de paciente femenina de 74 años de edad con estenosis aórtica severa y alto riesgo quirúrgico, que se trata con implantación valvular percutánea, con un adecuado desenlace clínico; constituye el primer caso manejado con esta nueva alternativa en el estado de Veracruz.
Transcatheter Aortic Valve Implantation: A new therapeutic option. Study of the first case carried out in the state of Veracruz
Abstract
Aortic valve stenosis is the most common valvulopathy worldwide, as well as in Mexico. The prognosis with medical treatment is unfavorable in the medium and long term, the treatment for more than 50 years has been the surgical valve replacement, and almost a third of the patients were considered at high risk and considered out of management. Since 2012, percutaneous valvular implantation in Mexico has been performed, thus providing a new therapeutic alternative to our patients increasingly established within the cardiological field of our country. Here we present the case of a 74 year-old female with severe aortic stenosis and high surgical risk treated with percutaneous valve implantation, with an adequate clinical outcome. This is the first case treated with this new alternative in the state of Veracruz, Mexico.
Citas
Adams, D., Popma, J., Reardon, M., Yakubov, S., Coselli, J., Deeb, G., et al. (2014). Transcatheter Aortic-Valve Replacement with a Self-Expanding Prosthe- sis. N Engl J Med, 370(1790), 8.
Cervantes, J. (2002). 50 Aniversario de la implantación de la primera válvula aórtica. Arch Cardiol Mex, 72(187), 91.
Cribier, A., Eltchaninoff, H., Bash, A., Borenstein, N., Tron, C., Bauer, F., et al. (2002). Percutaneous Transcatheter Implantation of an Aortic Valve Pros- thesis for Calcific Aortic Stenosis: First Human Case Description. Circulation, 106(3006), 8.
Cribier, A. (2014). The Odyssey of TAVR from Concept to Clinical Reality. Texas H Institute Journal, 41(125), 30.
Dobson, L., Musa, A., Fairbairn, T., Uddin, A., Blackman, D., Ripley, D., et al. (2015). CMR Assessment of Longitudinal Left Ventricular Function Following Transcatheter Aortic Valve Implantation (TAVI) for Severe Aortic Stenosis. Jour- nal of Cardiovascular Magnetic Resonance, 17(Suppl 1), 180.
Edwards, J. (1961). Calcific Aortic Stenosis: Pathologic Features. Proc Staff Mett Mayo Clin, 36(441), 51.
Gilard, M., Eltchaninoff, H., Lung, B., Donzeau-Gouge, P., Chevreul, K., Fajadet, J., et al. (2012). FRANCE 2 Registry of Transcatheter Aortic-Valve Implantation in High-Risk Patients. N Engl J Med, 366(1705), 15.
Grube, E., Schuler, G., Buellesfeld, L., Gerckens, U., Linke, A., Wenaweser, P., et al. (2007). Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in High-Risk Patients Using the Second- and Current Third-Generation SelfEex- panding CoreValve Prosthesis: Device Success and 30-Day Clinical Outcome. J Am Coll Cardiol, 50(69), 76.
Hamm C., Möllmann, H., Holzhey, D., Beckmann, A., Veit, C., Figulla, H., et al. (2014). The German Aortic Valve Registry (GARY): in-hospital outcome. Eur Heart J, 35(1588), 98.
Leon, M., Smith, C., Mack, M., Miller, D., Moses, J., Svensson, L., et al. (2010). Transcatheter Aortic-Valve Implantation for Aortic Stenosis in Patients Who Cannot Undergo Surgery. N Engl J Med, 363(1597), 607.
Leon, M., Smith, C., Mack, M., Makkar, R., Svensson, L., Kodali, S., et al. (2016). Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Pa- tients. N Engl J Med, 374(1609), 20.
Linke, A., Wenaweser, P., Gerckens, U., Tamburino, C., Bosmans, J., Bleiziffer, S., et al. (2014). Treatment of Aortic Stenosis with a Self-Expanding Transcatheter Valve: The International Multi-Centre ADVANCE Study. Eur Heart J, 35(2672), 84.
López-Aguilera, J., Segura, J., Mazuelos, F., Suárez de Lezo, S., Ojeda, S., Álva- rez-Ossorio, M., et al. (2016). Modificación de la conducción auriculoventricular tras el implante de prótesis aórtica CoreValve. Rev Esp Cardiol, 69(28), 36.
Lung, B., Baron, G., Butchart, E., Delahaye, F., Gohlke-Barwolf, C., Levang, O. (2003). A Prospective Survey of Patients with Valvular Heart Disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J, 24(1231), 43.
Lung, B., Cachier, A., Baron, G., Messika-Zeitoun, D., Delahaye, F., Tornos, P., et al. (2005). Decision-Making in Elderly Patients with Severe Aortic Stenosis: Why are so Many Denied Surgery? Eur Heart J, 26(2714), 20.
Moat, N., Ludman, P., De Belder, M., Bridgewater, B., Cunningham, A., Young, C., et al. (2011). Long-Term Outcomes after Transcatheter Aortic Valve Implantation in High-Risk Patients with Severe Aortic Stenosis: the UK TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol, 58(2130), 8.
Muñoz-García, A., Del Valle, R., Trillo-Nouche, R., Elízaga, J., Gimeno, F., Hernández-Antolín, R., et al. (2013). The Ibero-American Transcatheter Aortic Valve Implantation Registry with the CoreValve Prosthesis. Early and Long-Term Results. Int J Cardiol, 169(359), 65.
Nkomo, V., Gardin, J., Skelton, T., Gottdiener, J., Scott, C., Enriquez-Sarano, M. (2006). Burden of Valvular Heart Diseases: A Population-Based Study. Lancet, 368(1005), 11.
Piazza, N., Grube, E., Gerckens, U., Den Heijer, P., Linke, A., Luha, O., et al. (2008). Procedural and 30-Day Outcomes Following Transcatheter Aortic Valve Implantation Using the Third Generation (18F) CoreValve Revalving System: Re- sults from the Multicentre, Expanded Evaluation Registry 1-Year Following CE Mark Approval. EuroIntervention, 4(242), 9.
Roberts, W. (1970). Anatomically Isolated Aortic Valvular Disease: The Case Against its Being of Rheumatic Etiology. Am J Med, 49(151), 9.
Selser, A. (1987). Changing Aspects of the Natural History of Valvular Aortic Stenosis. New Engl J Med, 317(91), 8.
Smith, C., Leon, M., Mack, M., Miller, D., Moses, J., Svensson, L., et al. (2011). Transcatheter Versus Surgical Aortic-Valve Replacement in High-Risk Patients. N Engl J Med, 364(2187), 98.
Stephenson, L. (2008). History of Cardiac Surgery. Surgery in the adult. New York, EUA, McGraw-Hill Book Co.
Svensson, L., Blackstone, E., Rajeswaran, J., Brozzi, N., Leon, M., Smith, C., et al. (2014). Comprehensive Analysis of Mortality among Patients Undergoing TAVR: Results of the PARTNER Trial. J Am Coll Cardiol, 64(158), 68.
Schwarz, E., Bauman, P., Manthey, J., et al. (1982). The Effect of Aortic Valve Re- placement on Survival. Circulation, 66, 1105(10).
Thomas, M., Schymik, G., Walther, T., Himbert, D., Lefèvre, T., Treede, H., et al. (2010). Thirty-Day Results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: a European Registry of Transcatheter Aortic Valve implantation using the Edwards SAPIEN Valve. Circulation, 122(62), 9.
Ussia, G., Barbanti, M., Petronio, A., Tarantini, G., Ettori, F., Colombo, A., et al. (2012). Transcatheter Aortic Valve Implantation: 3-Year Outcomes of Self-Expand- ing CoreValve Prosthesis. Eur Heart J, 33(969), 76.
Wood, P. (1958). Aortic Stenosis. Am J Cardiol, 1(553), 71.
Esta obra está bajo una licencia internacional Creative Commons Atribución-NoComercial-SinDerivadas 4.0.
Derechos de autor 2023 http://creativecommons.org/licenses/by-nc-nd/4.0/